Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: High incidence of lymph node metastasis

Journal of Urology

Volumn 167, Issue 4 I, 2002, Pages 1681-1686

  Heidenreich, Axel ^a   Varga, Zoltan ^a   Von Knobloch, Rolf ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Lymph node excision; Lymph nodes; Neoplasm metastasis; Prostate; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SURGERY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; INCIDENCE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; METASTASIS; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SURGERY; PROSTATECTOMY; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0036129718     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)65177-4     Document Type: Article

References (23)

1. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A. Multi-institutional update
2. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: Development of a system of patient selection
3. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer
4. Evaluation of staging lymphadenectomy in prostate cancer
5. The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma
6. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma of the prostate with regional lymph node involvement
7. Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival?
8. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer
9. Prostate cancer: Anatomical and surgical considerations
10. Prostatic lymphography
11. An evaluation of lymphangiography in staging carcinoma of the prostate
12. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: Continued risk of biochemical failure after 5 years
13. Radical prostatectomy for the treatment of localized prostate carcinoma
14. Basic principles of ROC analysis
15. Is extensive lymph node dissection necessary in prostate cancer?
16. Survival of lymph node positive patients after radical prostatectomy
17. Extended lymphadenectomy for prostatic cancer
18. Pelvic lymphadectomy for stage B1 adenocarcinoma of the prostate: Justified or not?
19. Lymphogenic metastases in prostatic cancer: Operative and histopathologic investigations
20. Significance of staging pelvic lymphadectomy for prostatic cancer
21. Staging pelvic lymphadenectomy for carcinoma of the prostate: Risk versus benefit
22. Lymphography and pelvic lymphadenectomy in carcinoma of the prostate